Reaction
Postnatal Growth Restriction reporting signals
As of the last recalculation, Postnatal Growth Restriction appears in 114 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is RIMEGEPANT SULFATE (PRR 1,070.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rimegepant Sulfate | 45 | 1,070.5 | 1,074.3 |
| Butalbital, Acetaminophen, And Caffeine | 10 | 187.6 | 187.8 |
| Sumatriptan Succinate | 15 | 124.6 | 124.7 |
| Onabotulinumtoxina | 28 | 87.5 | 87.5 |
| Acetaminophen, Aspirin (Nsaid) And Caffeine | 6 | 67.9 | 68.0 |